Salidroside protects PC12 cells from MPP+-induced apoptosis via activation of the PI3K/Akt pathway

Food and Chemical Toxicology

Volumn 50, Issue 8, 2012, Pages 2591-2597

  Zhang, Lingling ^a   Ding, Wenjun ^a   Sun, Huixing ^d   Zhou, Qiong ^c   Huang, JingQun ^b   Li, Xuefen ^a   Xie, Yonghong ^c   Chen, Jianzong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d Guangming Hospital   (China)

Author keywords

Apoptosis; MPP+; Parkinson's disease; PC12 cells; PI3K Akt signaling pathway; Salidroside

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 2 MORPHOLINO 8 PHENYLCHROMONE; LACTATE DEHYDROGENASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SALIDROSIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; NONHUMAN; PHEOCHROMOCYTOMA CELL; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; ENZYME ACTIVATION; FLOW CYTOMETRY; GLUCOSIDES; L-LACTATE DEHYDROGENASE; PC12 CELLS; PHENOLS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS;

RATTUS; RHODIOLA ROSEA;

EID: 84862317174     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.05.045     Document Type: Article

References (65)

1. Ballard P.A., Tetrud J.W., Langston J.W. Permanent human parkinsonism due to 1-methy1-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neurology 1985, 35:949.
2. Bao W., Pan H., Lu M., Ni Y., Zhang R., Gong X. The apoptotic effect of sarsasapogenin from Anemarrhena asphodeloides on HepG2 human hepatoma cells. Cell. Biol. Int. 2007, 31:887-892.
3. Bartels A.L., Leenders K.L. Parkinson's disease: the syndrome, the pathogenesis and pathophysiology. Cortex 2009, 45:915-921.
4. Blum D., Torch S., Lambeng N., Nissou M.F., Benabid A.L., Sadoul R., Verna J.M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 2001, 65:135-172.
5. Bonda D.J., Wang X., Perry G., Nunomura A., Tabaton M., Zhu X., Smith M.A. Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology 2010, 59:290-294.
6. Chen X., Liu J., Gu X., Ding F. Salidroside attenuates glutamate-induced apoptotic cell death in primary cultured hippocampal neurons of rats. Brain Res. 2008, 1238:189-198.
7. Chong Z.Z., Kang J.Q., Maiese K. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 2002, 106:2973-2979.
8. Chong Z.Z., Kang J.Q., Maiese K. Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. Brit. J. Pharmacol. 2003, 138:1107-1118.
9. Chong Z.Z., Kang J.Q., Maiese K. AKT1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-xL and caspase 1, 3, and 9. Exp. Cell Res. 2004, 296:196-207.
10. Chong Z.Z., Li F., Maiese K. Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog. Neurobiol. 2005, 75:207-246.
11. De Lau L.M.L., Breteler M.M.B. Epidemiology of Parkinson's disease. Lancet Neurol. 2006, 5:525-535.
12. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 1986, 89:271-277.
13. Diermen D.V., Marston A., Bravo J., Reist M., Carrupt P.A., Hostettmann K. Monoamine oxidase inhibition by Rhodiola rosea L. roots. J. Ethnopharmacol. 2009, 122:397-401.
14. Duran R., Barrero F., Morales B., Luna J., Ramirez M., Vives F. Oxidative stress and plasma aminopeptidase activity in Huntington's disease. J. Neural. Transm. 2010, 117:325-332.
15. Fresno Vara J.A., Casado E., de Castro J., Cejas P., Belda-Iniesta C., Gonzalez-Baron M. PI3K/Akt signalling pathway and cancer. Cancer Treat. Rev. 2004, 30:193-204.
16. Fukui M., Choi H.J., Zhu B.T. Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radical Bio. Med. 2010, 49:800-813.
17. Götz J., Ittner L.M. Animal models of Alzheimer's disease and frontotemporal dementia. Nat. Rev. Neurosci. 2008, 9:532-544.
18. +)- and nerve growth factor-induced changes in pro- and anti-apoptotic signaling pathways in SH-SY5Y neuroblastoma cells. Brain Res. 2002, 952:98-110.
19. He Y., Lee T., Leong S.K. 6-Hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra. Brain Res. 2000, 858:163-166.
20. Henry M.K., Lynch J.T., Eapen A.K., Quelle F.W. DNA damage induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase/Akt signaling pathway. Blood 2001, 98:834-841.
21. Hu X., Zhang X., Qiu S., Yu D., Lin S. Salidroside induces cell-cycle arrest and apoptosis in human breast cancer cells. Biochem. Biophys. Res. Commun. 2010, 398:62-67.
22. Hu X., Lin S., Yu D., Qiu S., Zhang X., Mei R. A preliminary study: the anti-proliferation effect of salidroside on different human cancer cell lines. Cell Biol. Toxicol. 2010, 26:499-507.
23. +)-induced cell death in PC12 cells: inhibitory effects of several drugs. Neurochem. Int. 1994, 25:419-424.
24. Javitch J.A., D'Amato R.J., Strittmatter S.M., Snyder S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA 1985, 82:2173-2177.
25. Kang J.Q., Chong Z.Z., Maiese K. Akt1 protects against inflammatory microglial activation through maintenance of membrane asymmetry and modulation of cysteine protease activity. J. Neurosci. Res. 2003, 74:37-51.
26. Kang J.Q., Chong Z.Z., Maiese K. Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation. Mol. Pharmacol. 2003, 64:557-569.
27. Kanthasamy A., Jin H., Mehrotra S., Mishra R., Kanthasamy A., Rana A. Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease. Neuro. Toxicol. 2010, 31:555-561.
28. Kim E.K., Choi E.J. Pathological roles of MAPK signaling pathways in human diseases. BBA-Mol. Basis Dis. 2010, 1802:396-405.
29. Koh J.Y., Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods 1987, 20:83-90.
30. Koh S.H., Kim S.H., Kwon H., Park Y., Kim K.S., Song C.W., Kim J., Kim M.H., Yu H.J., Henkel J.S., Jung H.K. Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3. Mol. Brain Res. 2003, 118:72-81.
31. Koh S.H., Kim S.H., Kwon H., Kim J.G., Kim J.H., Yang K.H., Kim J., Kim S.U., Yu H.J., Do B.R., Kim K.S., Jung H.K. Phosphatidylinositol-3 kinase/Akt and GSK-3 mediated cytoprotective effect of epigallocatechin gallate on oxidative stress-injured neuronal-differentiated N18D3 cells. Neurotoxicology 2004, 25:793-802.
32. +) model of Parkinson's disease. Biochem. Biophys. Res. Commun. 2011, 411:370-374.
33. Kösel S., Egensperger R., von Eitzen U., Mehraein P., Graeber M.B. On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropathol. 1997, 93:105-108.
34. Kwon S.H., Hong S.I., Kim J.A., Jung Y.H., Kim S.Y., Kim H.C., Lee S.Y., Jang C.G. The neuroprotective effects of Lonicera japonica THUNB against hydrogen peroxide-induced apoptosis via phosphorylation of Makes and PI3K/Akt in SH-SY5Y cells. Food Chem. Toxicol. 2011, 49:1011-1019.
35. Leung K.W., Yung K.K.L., Mak N.K., Chan Y.S., Fan T.P., Wong R.N.S. Neuroprotective effects of ginsenoside-Rg1 in primary nigral neurons against rotenone toxicity. Neuropharmacology 2007, 52:827-835.
36. Lev N., Melamed E., Offen D. Apoptosis and Parkinson's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003, 27:245-250.
37. Levy O., Malagelada C., Greene L. Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps. Apoptosis 2009, 14:478-500.
38. Li M., Donglian C., Huaixing L., Bende T., Lihua S., Ying W. Anti-fatigue effects of salidroside in mice. J. Med. Coll. PLA 2008, 23:88-93.
39. +-induced apoptosis in PC12 cells by inhibiting the NO pathway. Brain Res. 2011, 1382:9-18.
40. Liang X.Q., Xie P., Zhang Y., Shi T., Yan T.H., Wang Q.J. Effects of salidroside on myocardial ischemia/reperfusion injury in rats. Chin. J. Nat. Med. 2010, 2010(8):127-131.
41. Lotharius J., Dugan L.L., O'Malley K.L. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J. Neurosci. 1999, 19:1284-1293.
42. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
43. 2 partly through modulating oxidative status. Mech. Ageing Dev. 2010, 131:723-731.
44. Mao G.X., Deng H.B., Yuan L.G., Li D.D., Yvonne Li Y.Y., Wang Z. Protective role of salidroside against aging in a mouse model induced by d-galactose. Biomed. Environ. Sci. 2010, 23:161-166.
45. Marsden C.D. Parkinson's disease. Lancet 1990, 335:948-952.
46. Matsuzaki H., Tamatani M., Mitsuda N., Namikawa K., Kiyama H., Miyake S., Tohyama M. Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons. J. Neurochem. 1999, 73:2037-2046.
47. Mutoh T., Tokuda A., Marini A.M., Fujiki N. 1-Methyl-4-phenylpyridinum kills differentiated PC12 cells with a concomitant change in protein phosphorylation. Brain Res. 1994, 661:51-55.
48. Ormerod M.G., Collins M.K.L., Rodriguez-Tarduchy G., Robertson D. Apoptosis in interleukin-3-dependent haemopoietic cells: quantification by two flow cytometric methods. J. Immunol. Methods 1992, 153:57-65.
49. Parkinson J. An Assay on the Shaking Palsy 1817, Sherwood, Neely and Jones, London, 1-66.
50. Pienaar I.S., Götz J.r., Feany M.B. Parkinson's disease: insights from non-traditional model organisms. Prog. Neurobiol. 2010, 92:558-571.
51. Ruan H., Yang Y., Zhu X., Wang X., Chen R. Neuroprotective effects of (±catechin against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mice. Neurosci. Lett. 2009, 450:152-157.
52. Salinas M., Martin D., Alvarez A., Cuadrado A. Akt1/PKB[alpha] protects PC12 Cells against the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium and reduces the levels of oxygen-free radicals. Mol. Cell Neurosci. 2001, 17:67-77.
53. Tasaki Y., Omura T., Yamada T., Ohkubo T., Suno M., Iida S., Sakaguchi T., Asari M., Shimizu K., Matsubara K. Meloxicam protects cell damage from 1-methyl-4-phenyl pyridinium toxicity via the phosphatidylinositol 3-kinase/Akt pathway in human dopaminergic neuroblastoma SH-SY5Y cells. Brain Res. 2010, 1344:25-33.
54. Tatton W.G., Chalmers-Redman R.M.E., Ju W.J.H., Mammen M., Carlile G.W., Pong A.W., Tatton N.A. Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 Cells. J. Pharmacol. Exp. Ther. 2002, 301:753-764.
55. Timmons S., Coakley M.F., Moloney A.M.C., Neill O'. Akt signal transduction dysfunction in Parkinson's disease. Neurosci. Lett. 2009, 467:30-35.
56. Toulouse A., Sullivan A.M. Progress in Parkinson's disease - Where do we stand?. Prog. Neurobiol. 2008, 85:376-392.
57. Tsang A.H.K., Chung K.K.K. Oxidative and nitrosative stress in Parkinson's disease. BBA-Mol. Basis Dis. 2009, 1792:643-650.
58. Tuler S.M., Hazen A.A., Bowen J.M. Release and metabolism of dopamine in a clonal line of pheochromocytoma (PC12) cells exposed to fenthion. Fundam. Appl. Toxicol. 1989, 13:484-492.
59. Wang T., Gu J., Wu P.F., Wang F., Xiong Z., Yang Y.J., Wu W.N., Dong L.D., Chen J.G. Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-κB pathways and inhibition of intracellular ROS/RNS generation. Free Radical Bio. Med. 2009, 47:229-240.
60. Wang W., Sun F., An Y., Ai H., Zhang L., Huang W., Li L. Morroniside protects human neuroblastoma SH-SY5Y cells against hydrogen peroxide-induced cytotoxicity. Eur. J. Pharmacol. 2009, 613:19-23.
61. Winklhofer K.F., Haass C. Mitochondrial dysfunction in Parkinson's disease. BBA-Mol. Basis Dis. 2010, 1802:29-44.
62. Wirdefeldt K., Adami H.O., Cole P., Trichopoulos D., Mandel J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur. J. Epidemiol. 2011, 26:1-58.
63. Zhang L., Yu H., Sun Y., Lin X., Chen B., Tan C., Cao G., Wang Z. Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Eur. J. Pharmacol. 2007, 564:18-25.
64. Zhang L., Yu H., Zhao X., Lin X., Tan C., Cao G., Wang Z. Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells. Neurochem. Int. 2010, 57:547-555.
65. Zhu Y., Shi Y., Wu D., Ji Ya., Wang X., Chen H., Wu S., Huang D., Jiang W. Salidroside protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via PI3K-Akt dependent pathway. DNA Cell Biol. 2011, 30:809-819.